StockClub

ANIP

ANIPANI Pharmaceuticals, Inc.$ --
ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

ANIP

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

analyticsEarnings Summary

FY2025 Q4Updated: 12/31/2025

Revenue

attach_money
247M USD
-

Operating Income

trending_up
48M USD
-

Net Income

verified
27M USD
-

EPS

paid
1.24$
-

Revenue

$247.1M

BEAT
$180.6M
$197.1M
Q1
$190.1M
$211.4M
Q2
$212.8M
$227.8M
Q3
$231.1M
$247.1M
Q4
$814.7M
$883.4M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-

Net Income

$27.5M

MISS
$29.3M
$15.7M
Q1
$29.8M
$8.5M
Q2
$37.6M
$24.1M
Q3
$42.3M
$27.5M
Q4
$139M
$75.9M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-

Surprise History

ActualEstimate
FY2025BEAT
$883.4M

Future Forecast